NSE - Delayed Quote INR

Nectar Lifesciences Limited (NECLIFE.NS)

Compare
38.25
+0.32
+(0.84%)
At close: January 10 at 3:14:18 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Sanjiv Goyal Chairman & MD 22.65M -- 1960
Mr. Puneet Sud B.Tech. Director of Operations & Wholetime Director 6.46M -- 1967
Mr. Amit Chadah Chief Executive Officer -- -- 1970
Mr. Sushil Kapoor Chief Financial Officer -- -- 1958
Ms. Neha Vaishnav Company Secretary & Compliance Officer -- -- --

Nectar Lifesciences Limited

SCO 38-39
Sector 9d
Chandigarh, 160009
India
91 17 2504 7915 https://www.neclife.com
Sector: 
Healthcare
Full Time Employees: 
1,686

Description

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Corporate Governance

Nectar Lifesciences Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 12, 2025 at 10:59 AM UTC - February 17, 2025 at 12:00 PM UTC

Nectar Lifesciences Limited Earnings Date

Recent Events

September 21, 2020 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers